2 unknown, 1 completed. 1 Not applicable, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Command Hospital, India: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Study the Impact of Stopping Therapy in Patients of CML With Molecular Remission Stopping the standard drug therpy, Quantitative bcrabl recording every month for first 6 months - Chronic Myeloid Leukemia, Treatment Free Remission | Not applicable | Unknown | Command Hospital, India | 27 | 2017-08-01 | 2019-07-23 |
| A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease Saroglitazar, Pioglitazone - Fatty Liver | Phase 3 | Unknown | Command Hospital, India | 100 | 2014-10-01 | 2014-10-16 |
| Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus Insulin, Sitagliptin, Exenatide - Type 1 Diabetes | Phase 4 | Completed | Command Hospital, India | 20 | 2010-11-01 | 2016-07-27 |
Diabetes Mellitus (1) · Diabetes Mellitus, Type 1 (1) · Fatty Liver (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Non-alcoholic Fatty Liver Disease (1)
Dipeptidyl-Peptidase IV Inhibitors (1) · Exenatide (1) · Insulin (1) · Pioglitazone (1) · Sitagliptin Phosphate (1) · saroglitazar (1)
India (3)
Hari Kumar, MD (1) · The Commandant, MD (1)